Citigroup
BNR

Citigroup’s Burning Rock Biotech BNR Stock Holding History

Citigroup’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$16 – 5759
2026
Q1 		$16 Hold
1
– – ﹤0.01% 5705
2025
Q4 		$20 Buy
+1
New +$15 ﹤0.01% 5775
2025
Q1 		– Sell
-31
Closed -$209 – 5604
2024
Q4 		$209 Buy
+31
New +$143 ﹤0.01% 5661
2022
Q4 		– Sell
-6
Closed – – 5786
2022
Q3 		$0 Hold
6
– – ﹤0.01% 5844
2022
Q2 		$0 Sell
6
-1,767
-100% -$78.9K ﹤0.01% 6248
2022
Q1 		$165K Sell
1,773
-662
-27% -$57.5K ﹤0.01% 4172
2021
Q4 		$232K Sell
2,435
-1,890
-44% -$259K ﹤0.01% 4277
2021
Q3 		$773K Sell
4,325
-184
-4% -$40.9K ﹤0.01% 3287
2021
Q2 		$1.33M Buy
4,509
+4,145
+1,139% +$1.23M ﹤0.01% 3003
2021
Q1 		$98K Buy
+364
New +$111K ﹤0.01% 4375

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CL
CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup's BNR Position: Q2 2026 in Review

Citigroup sold out of Burning Rock Biotech (BNR) in Q2 2026, closing a stake of 1 share — an estimated $16 sold.

Citigroup first reported a position in BNR in Q1 2021 and held it in 10 quarters. The position peaked at $1.33M in Q2 2021. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Citigroup reported no remaining Burning Rock Biotech position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 1 Burning Rock Biotech share in Q2 2026, an estimated $16.
  • Citigroup first reported a position in Burning Rock Biotech in Q1 2021 and held it in 10 quarters.
  • Citigroup's Burning Rock Biotech position peaked at $1.33M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.